Teva issues about $4.9B in notes; shifts ADS to NYSE
Teva Pharmaceutical Industries is refinancing debt with roughly $4.9B/€1.5B in notes and converting its ADS into ordinary shares for NYSE trading.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.